Acute myeloid leukemia (AML) is a heterogeneous disorder characterized by a wide range
of genetic defects. Cytogenetics, molecular and genomic technologies have proved to be …

Objectives: The study aims to understand geneome diversification and complexity that
developed in Acute myeloid leukemia (AML). Methods: Next-generation sequencing (NGS) …

Acute myeloid leukemia (AML) identifies a heterogeneous group of clonal disorders, both
clinically and genetically. A large number of mutations have been described in AML …

Acute myeloid leukemia (AML) is a clonal disorder of the blood forming cells characterized
by accumulation of immature blast cells in the bone marrow and peripheral blood. Being a …

Background/Aim: Acute myeloid leukemia (AML) represents a heterogeneous disease with
varying morphologic, immunophenotypic, and genetic features, along with varying patient …

Abstract Acute Myeloid Leukemia (AML) is a heterogeneous disease with poor overall five-
year survival of less than 30%. Current risk stratification is largely based on cytogenetics …

The aim of the present study was to examine the associations between 112 acute myeloid
leukaemia (AML)‑associated genes and the prognosis and clinical features of AML using …

Background Acute myeloid leukaemia (AML) results from the clonal expansion of blast cells
of myeloid origin driven by genomic defects. The advances in next‐generation sequencing …

Acute myeloid leukemia (AML) is a complex hematologic malignancy with high morbidity
and mortality. Nucleophosmin 1 (NPM1) mutations occur in approximately 30% of AML …

Acute myeloid leukemia (AML) is characterized by recurrent genetic alterations, including
amplifications, deletions, rearrangements, and point mutations. Clinically, these lesions can …